BrainBalance
Minimally Invasive Device for the Treatment of Alzheimer's Disease
Health Tech & Life Sciences
Private
Company Overview
Snapshot
Founded in June 2016, BrainBalance operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its core technology.
Business overview
BrainBalance is a Health Tech & Life Sciences company developing a minimally invasive device for the treatment of Alzheimer's Disease. Its technology utilizes a directional electrical field to enhance the natural clearance of Aβ from brain parenchyma to the cerebrospinal fluid, aiming to restore homeostasis in the extracellular environment and halt disease progression. The company operates within the Medical Devices, Medical Treatment & Therapeutics sectors, targeting the healthcare market.
Log in to access full profile ›Company Intelligence Q&A
- What is BrainBalance's primary focus?
- BrainBalance is focused on developing a minimally invasive device for the treatment of Alzheimer's Disease, utilizing a directional electrical field to clear Aβ from brain parenchyma.
- When was BrainBalance founded?
- BrainBalance was founded in June 2016.
- What stage of funding is BrainBalance currently in?
- BrainBalance is currently in the Pre-Funding stage, as of its last update in December 2020. The company has not yet disclosed any funding rounds.
- What is BrainBalance's product development stage?
- BrainBalance's product is currently in the R&D stage, as of its last update in December 2020.
- Which sectors does BrainBalance operate in?
- BrainBalance operates in the Health Tech & Life Sciences sector, specifically within Medical Devices and Medical Treatment & Therapeutics.